Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial
Dorosti M, Jafary Heidarloo A, Bakhshimoghaddam F, Alizadeh M
The British journal of nutrition · 61 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
- Consumo medido con
- No se indica
Quién lo pagó
- Financiación
- Financiación independiente
- Universidad u hospital
- Urmia University
- Universidad u hospital
- Urmia University of Medical Sciences
Según 2 financiadores declarados.
Publicación
- Publicado
- 2019-11-05 · Br J Nutr · vol. 123 · número 3 · págs. 328–336
- Editorial
- Cambridge University Press
- Citado
- 73 citas · más que el 93% de estudios similares · 3.4× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 37 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Liver Disease Diagnosis and Treatment · Diet, Metabolism, and Disease · Food composition and properties
- Palabras clave
- Medicine, Fatty liver, Steatosis, Internal medicine, Gastroenterology, Triglyceride, Blood pressure, Anthropometry, Disease, Cholesterol
- MeSH
- liver, humans, gamma-glutamyltransferase, alanine transaminase, aspartate aminotransferases, treatment outcome, eating, adult, middle aged, female, male, non-alcoholic fatty liver disease, edible grain, whole grains
4 autores
- Masoumeh Dorosti🇮🇷Urmia University; Urmia University of Medical Sciences
- Ali Jafary Heidarloo🇮🇷Imam Khomeini Hospital; Urmia University; Urmia University of Medical Sciences
- Farnush Bakhshimoghaddam🇮🇷Urmia University; Urmia University of Medical Sciences
- Mohammad Alizadeh🇮🇷 · autor de correspondenciaUrmia University; Urmia University of Medical Sciences
Resumen
El texto original del estudio, en el idioma en que se publicó.
Non-alcoholic fatty liver disease (NAFLD) is a considerable challenge to public health across the globe. Whole grain is highly recommended as an inseparable part of a healthy diet and has been proposed as an effective way to manage NAFLD. The objective in the present study was to evaluate the effects of whole-grain consumption on hepatic steatosis and liver enzymes as primary outcomes in patients with NAFLD. Over the 12 weeks of this open-label, randomised controlled clinical trial, 112 patients (mean age 43 (sd 8·7) years; BMI 32·2 (sd 4·3) kg/m2) were randomly assigned to two groups to receive dietary advice, either to obtain at least half of their cereal servings each day from whole-grain foods or from usual cereals. By the end of the study, the grades of NAFLD showed a significant decrease in the intervention group (P < 0·001). In addition, a significant reduction in serum concentration of alanine aminotransferase (P < 0·001), aspartate aminotransferase (P < 0·001), γ-glutamyltransferase (P = 0·009), systolic blood pressure (P = 0·004) and diastolic blood pressure (P = 0·008) was observed in the intervention group compared with the control group. After adjusting, however, no significant differences were found between the two groups in terms of lipid profile, glycaemic status and anthropometric measurements. Overall, our study demonstrated that consumption of whole grains for 12 weeks had beneficial effects on hepatic steatosis and liver enzymes concentrations in patients with NAFLD.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.